ESC Premium Access

Recurrent venous thromboembolism and major bleeding in patients treated with rivaroxaban or warfarin for venous thromboembolism in routine practice

Congress Session

About the speaker

Doctor Craig Coleman

University of Connecticut , Storrs (United States of America)
10 presentations
0 follower

6 more presentations in this session

Long-term effects of unprovoked venous thromboembolism on mortality and major cardiovascular events

Speaker: Doctor W. Chang (Tainan, TW)

Thumbnail

Comparative safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism - a Danish nationwide study

Speaker: Ms C. Sindet-Pedersen (Hellerup, DK)

Thumbnail

Validation of the prognostic impact of copeptin in normotensive pulmonary embolism in a european multicentre study.

Speaker: Doctor K. Hellenkamp (Goettingen, DE)

Thumbnail

A novel experimental in vivo model of acute pulmonary embolism

Speaker: Doctor J. Schultz (Aarhus, DK)

Thumbnail

The YEARS algorithm for suspected pulmonary embolism leads to much shorter diagnostic turnaround time than conventional algorithms

Speaker: Doctor E. Klok (Leiden, NL)

Thumbnail

Access the full session

What is new in venous thromboembolism?

Speakers: Doctor C. Coleman, Doctor W. Chang, Ms C. Sindet-Pedersen, Doctor K. Hellenkamp, Doctor J. Schultz...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk